| Dr Timothy E Freyaldenhoven, MD | |
|
2200 Ada Ave Ste 302, Conway, AR 72034-4985 | |
| (501) 932-0352 | |
| (501) 932-0354 |
| Full Name | Dr Timothy E Freyaldenhoven |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 26 Years |
| Location | 2200 Ada Ave Ste 302, Conway, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174520258 | NPI | - | NPPES |
| 146351001 | Medicaid | AR | |
| 130025088 | Other | AR | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | E-3108 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Conway Regional Health System | Conway, AR | Hospital |
| Arkansas Heart Hospital, Llc | Little rock, AR | Hospital |
| St Vincent Medical Center/north | Sherwood, AR | Hospital |
| Baptist Health Medical Center- Conway | Conway, AR | Hospital |
| Entity Name | Arkansas Neurology, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821059759 PECOS PAC ID: 2466597026 Enrollment ID: O20100306000340 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
Acne is a serious medical condition. More than 40 percent of mid-teens and adolescents have either acne or acne scarring requiring professional treatment by a dermatologist. Unfortunately, nationwide statistics show that only 11 percent of patients receive treatment.
At any given moment, the human genome spells out thousands of genetic words telling our cells which proteins to make. Each word is read by a molecule known as a tRNA.
Among homeless individuals cardiovascular disease remains one of the major causes of death due to challenges in predicting initial risk, limited access to health care and difficulties in long-term management, according to a review published today in the Journal of the American College of Cardiology.
A newly developed filter, which removes more than 99 percent of heavy metal toxins from water, shows potential for water remediation in developing nations around the world.
› Verified 5 days ago
| Entity Name | Conway Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255879656 PECOS PAC ID: 3173428414 Enrollment ID: O20170403000499 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
Acne is a serious medical condition. More than 40 percent of mid-teens and adolescents have either acne or acne scarring requiring professional treatment by a dermatologist. Unfortunately, nationwide statistics show that only 11 percent of patients receive treatment.
At any given moment, the human genome spells out thousands of genetic words telling our cells which proteins to make. Each word is read by a molecule known as a tRNA.
Among homeless individuals cardiovascular disease remains one of the major causes of death due to challenges in predicting initial risk, limited access to health care and difficulties in long-term management, according to a review published today in the Journal of the American College of Cardiology.
A newly developed filter, which removes more than 99 percent of heavy metal toxins from water, shows potential for water remediation in developing nations around the world.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy E Freyaldenhoven, MD 2200 Ada Ave Ste 302, Conway, AR 72034-4985 Ph: (501) 932-0352 | Dr Timothy E Freyaldenhoven, MD 2200 Ada Ave Ste 302, Conway, AR 72034-4985 Ph: (501) 932-0352 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
Acne is a serious medical condition. More than 40 percent of mid-teens and adolescents have either acne or acne scarring requiring professional treatment by a dermatologist. Unfortunately, nationwide statistics show that only 11 percent of patients receive treatment.
At any given moment, the human genome spells out thousands of genetic words telling our cells which proteins to make. Each word is read by a molecule known as a tRNA.
Among homeless individuals cardiovascular disease remains one of the major causes of death due to challenges in predicting initial risk, limited access to health care and difficulties in long-term management, according to a review published today in the Journal of the American College of Cardiology.
A newly developed filter, which removes more than 99 percent of heavy metal toxins from water, shows potential for water remediation in developing nations around the world.
› Verified 5 days ago
Douglas G Callahan, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 350 Salem Road, Ste 1, Conway, AR 72034 Phone: 501-336-8300 Fax: 501-329-3572 | |
Dr. Keith O Schluterman, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2200 Ada Ave Ste 302, Conway, AR 72034 Phone: 501-932-0352 Fax: 501-932-0354 | |
Asim Raza, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 350 Salem Road, Ste 1, Conway, AR 72034 Phone: 501-336-8300 Fax: 501-329-3572 | |
Dr. David E. Anderson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2525 College Ave, Conway, AR 72034 Phone: 501-712-1998 Fax: 501-712-1999 | |
Atif M Akhtar, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 350 Salem Rd Ste 1, Conway, AR 72034 Phone: 501-336-8300 Fax: 501-329-5508 | |
Lauren Davis, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2215 E Oak St Ste 1, Conway, AR 72032 Phone: 501-336-0511 Fax: 501-336-4037 |